Luca Guardabassi graduated in veterinary medicine from the University of Pisa in 1994 and completed his PhD in veterinary microbiology at the University of Copenhagen in 2000, where he works as professor since 2012. He has published more than 200 peer-reviewed articles, mainly addressing issues related to AMR and antimicrobial therapy. His research covers a broad range of topics interlinked with AMR, from epidemiological and evolutionary studies on multidrug-resistant bacteria to development and testing new antibiotics drug targets, alternatives to antibiotics, and rapid diagnostic tests for guiding antimicrobial use.
Among his honorary offices, Luca is chair of the Therapeutic Guidelines Group in the World Small Animal Veterinary Association (WSAVA), vice-chair of the Scientific Advisory Board in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), and Science Officer of the Study Group for Veterinary Microbiology (ESGVM) in the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). He has been involved in several national and international committees for the development of practice guidelines for rational antimicrobial use in animals.